EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis

Jucheng Zhang, Xiaohui Zhang, Yan Zhong, Jing Wang, Chao Zhong, Meiling Xiao, Yuhan Chen, Hong Zhang iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07069-6 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Jucheng Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Positron-Emission Tomography, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To systematically review the literature and perform a meta-analysis of PET radiomics for histologic subtype classification in non-small cell lung cancer (NSCLC). METHODS: PubMed, Embase, Scopus, and Web of Science databases were systematically searched in English on human subjects for studies on distinguishing adenocarcinoma (ADC) from squamous cell carcinoma (SCC) using PET radiomics published from inception until November 2024. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Radiomics Quality Score (RQS) were utilized to assess the methodological quality of the included studies. The area under the receiver operating characteristic curves (AUC) was pooled to estimate predictive performance. An overall effect size was estimated using a random-effects model. Statistical heterogeneity was evaluated by the I2 value. Subgroup analyses were conducted to explore sources of heterogeneity. RESULTS: Twelve studies were included in the analysis, yielding a pooled AUC of 0.92 (95% confidence interval [CI]: 0.89-0.94). Despite this promising result, the studies showed limitations in both study design and methodological quality, as evidenced by a median RQS of 11/36. A significant degree of heterogeneity was observed among the studies, with an I2 of 92.20% (95% CI: 89.01-95.39) for sensitivity and 89.29% (95% CI: 84.48-94.10) for specificity. CONCLUSIONS: This meta-analysis highlights the potential utility of PET radiomics in distinguishing ADC from SCC. However, the observed high heterogeneity indicates substantial methodological variability across the included studies. Future research should focus on standardization, transparency, and multicenter collaborations to improve the reliability and clinical applicability of PET radiomics for histologic subtype classification in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPositron-Emission TomographyImage Processing, Computer-AssistedHumansRadiomics

Stichwörter der Autor:innen

Histologic subtypeNSCLCPositron emission tomography (PET)Radiomics

Autor:innen und Institutionen

  • Department of Clinical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
  • Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China.
  • Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
  • Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
  • Department of Radiology, Ningbo Yinzhou NO.2 Hospital, Ningbo, Zhejiang, 315192, China.
  • Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China. hzhang21@zju.edu.cn.

ORCID-Profile: Hong Zhang

Förderung

  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhang, J., Zhang, X., Zhong, Y., Wang, J., Zhong, C., Xiao, M., Chen, Y., & Zhang, H. (2025). PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07069-6

Vancouver

Zhang J, Zhang X, Zhong Y, Wang J, Zhong C, Xiao M, et al. PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07069-6

BibTeX
@article{Zhang2025,
  author = {Zhang, Jucheng and Zhang, Xiaohui and Zhong, Yan and Wang, Jing and Zhong, Chao and Xiao, Meiling and Chen, Yuhan and Zhang, Hong},
  title = {PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07069-6}
}
Kostenlos starten →